LPTX icon

Leap Therapeutics
LPTX

Overview Fund Activity

25 hedge funds and large institutions have $17.8M invested in Leap Therapeutics in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
25
Holders Change
+5
Holders Change %
+25%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$403K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$2M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.08M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$111K
5
DS
5
DRW Securities
Illinois
$378K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$7.17M
2
SFM
2
Sphera Funds Management
Israel
$2.59M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$0
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$0
5
DCM
5
DAFNA Capital Management
California
$1.1M
Name Market Value Shares Shares
Change 		Shares
Change %
APSP
26
Asset Planning Services (Pennsylvania)
Pennsylvania
$0 100 – –
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$0 13 +13 New
1
2